PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024
PROCEPT BioRobotics (Nasdaq: PRCT), a surgical robotics company specializing in urology solutions, has announced its plans to release third quarter 2024 financial results on October 28, 2024, before the market opens. The company will host a conference call at 8:00 a.m. Eastern Time on the same day to discuss the results.
Interested parties can access the call through a webcast link or a dial-in registration for sell-side research analysts. The live audio webcast and an archived recording will be available on the company's investor relations website. The webcast replay will be accessible for at least 90 days after the event.
PROCEPT BioRobotics (Nasdaq: PRCT), un'azienda di robotica chirurgica specializzata in soluzioni urologiche, ha annunciato i suoi piani per rilasciare i risultati finanziari del terzo trimestre 2024 il 28 ottobre 2024, prima dell'apertura del mercato. L'azienda ospiterà una conferenza telefonica alle 8:00 a.m. Eastern Time lo stesso giorno per discutere i risultati.
Le parti interessate possono accedere alla chiamata tramite un link per webcast o una registrazione telefonica per gli analisti di ricerca sell-side. Il webcast audio dal vivo e una registrazione archiviata saranno disponibili sul sito web delle relazioni con gli investitori dell'azienda. La riproduzione del webcast sarà accessibile per almeno 90 giorni dopo l'evento.
PROCEPT BioRobotics (Nasdaq: PRCT), una empresa de robótica quirúrgica especializada en soluciones urológicas, ha anunciado sus planes para publicar los resultados financieros del tercer trimestre de 2024 el 28 de octubre de 2024, antes de la apertura del mercado. La empresa llevará a cabo una conferencia telefónica a las 8:00 a.m. Eastern Time el mismo día para discutir los resultados.
Las partes interesadas pueden acceder a la llamada a través de un enlace de webcast o una registración telefónica para analistas de investigación de ventas. El webcast en vivo y una grabación archivada estarán disponibles en el sitio web de relaciones con inversionistas de la empresa. La repetición del webcast estará accesible durante al menos 90 días después del evento.
PROCEPT BioRobotics (Nasdaq: PRCT), 신장 솔루션 전문 외과 로봇 회사,는 2024년 3분기 재무 결과를 2024년 10월 28일, 시장 개장 전에 발표할 계획을 발표했습니다. 회사는 같은 날 동부 표준시 기준 오전 8시에 결과에 대해 논의하기 위한 전화 회의를 개최합니다.
관심 있는 당사자는 웹캐스트 링크 또는 판매 측 연구 분석가를 위한 전화 등록을 통해 전화를 접속할 수 있습니다. 라이브 오디오 웹캐스트와 보관된 녹음은 회사의 투자자 관계 웹사이트에서 이용할 수 있습니다. 웹캐스트 재생은 이벤트 후 최소 90일 동안 접근 가능합니다.
PROCEPT BioRobotics (Nasdaq: PRCT), une entreprise de robotique chirurgicale spécialisée dans les solutions urologiques, a annoncé son intention de publier les résultats financiers du troisième trimestre 2024 le 28 octobre 2024, avant l'ouverture du marché. L'entreprise organisera une conférence téléphonique à 8h00 heure de l'Est le même jour pour discuter des résultats.
Les parties intéressées peuvent accéder à l'appel via un lien de webdiffusion ou une inscription par téléphone pour les analystes de recherche du côté des ventes. La webdiffusion audio en direct et un enregistrement archivé seront disponibles sur le site Web des relations avec les investisseurs de l'entreprise. La rediffusion de la webdiffusion sera accessible pendant au moins 90 jours après l'événement.
PROCEPT BioRobotics (Nasdaq: PRCT), ein Unternehmen für chirurgische Robotik, das sich auf urologische Lösungen spezialisiert hat, hat seine Pläne angekündigt, die Finanzergebnisse für das dritte Quartal 2024 am 28. Oktober 2024, vor Markteröffnung zu veröffentlichen. Das Unternehmen wird am selben Tag um 8:00 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen.
Interessierte Parteien können über einen Webcast-Link oder eine Telefonregistrierung für Sell-Side-Research-Analysten anrufen. Das Live-Audio-Webcast und eine archivierte Aufnahme werden auf der Website der Investor Relations des Unternehmens verfügbar sein. Die Wiederholung des Webcasts wird mindestens 90 Tage nach der Veranstaltung zugänglich sein.
- None.
- None.
SAN JOSE, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the third quarter of 2024 before market open on Monday, October 28, 2024. The Company’s management will host a corresponding conference call beginning at 8:00 a.m. Eastern Time.
Investors interested in listening to the conference call may do so by following one of the below links:
- Webcast link for interested listeners:
- Dial-in registration for sell-side research analysts:
Live audio of the webcast will be available on the “Investors” section of the Company’s website at: https://ir.procept-biorobotics.com.
An archived recording will be available on the “Investors” section of the Company’s website at: https://ir.procept-biorobotics.com. Each webcast will be available for replay for at least 90 days after the event.
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. PROCEPT BioRobotics manufactures the AQUABEAM® and HYDROS™ Robotic Systems. The HYDROS Robotic System is the only AI-Powered, robotic technology that delivers Aquablation therapy. PROCEPT BioRobotics designed Aquablation therapy to deliver effective, safe, and durable outcomes for males suffering from lower urinary tract symptoms or LUTS, due to BPH that are independent of prostate size and shape or surgeon experience. BPH is the most common prostate disease and impacts approximately 40 million men in the United States. The Company has developed a significant and growing body of clinical evidence with over 150 peer-reviewed publications, supporting the benefits and clinical advantages of Aquablation therapy.
Investor Contact:
Matt Bacso
VP, Investor Relations and Business Operations
m.bacso@PROCEPT-BioRobotics.com
FAQ
When will PROCEPT BioRobotics (PRCT) report its Q3 2024 financial results?
What time is PROCEPT BioRobotics' (PRCT) Q3 2024 earnings call scheduled for?
How can investors access PROCEPT BioRobotics' (PRCT) Q3 2024 earnings call?
Where can I find the replay of PROCEPT BioRobotics' (PRCT) Q3 2024 earnings call?
